TUCSON, AZ and PARIS--(Marketwire - November 05, 2007) - CDEX, Inc. (OTCBB: CEXI) follows up on its record quarter in ValiMed™ sales/leases to U.S. hospitals by announcing that Mr. Pascal Pouligny has joined CDEX as Vice President of International Sales and Marketing to launch ValiMed into the International health care and hospital markets. The ValiMed Medication Validation System uses Enhanced Photoemission Spectroscopy to quickly validate high-risk medication admixtures, as well as returned narcotics, to provide an increased level of patient safety. ValiMed compares a medication's spectroscopic signature to the expected signature from the CDEX Medication Signature Library and returns an easy to understand "validated" or "not validated" result, requiring no user interpretation.
